2021

Researchers define the clinical characteristics of the cerebral complications caused by oncological immunotherapies that determine the evolution

The study describes two syndromes, which combine clinical manifestations and differential cerebrospinal fluid profiles, which determine a different prognosis in patients.

Researchers define the clinical characteristics of the cerebral complications caused by oncological immunotherapies that determine the evolution Read More »

A study predicts that in 2030 there will be more cases and more deaths from endometrial cancer in Catalonia among women over 65 years-old

The data obtained show a decrease in the incidence and a slight increase in mortality from endometrial cancer. The study was conducted by the Infections and Cancer research group from IDIBELL, ICO, and the Oncology Master Plan.

A study predicts that in 2030 there will be more cases and more deaths from endometrial cancer in Catalonia among women over 65 years-old Read More »

Dr. Xavier Matias-Guiu, the new president of the International Society of Gynecological Pathologists

Dr. Xavier Matias-Guiu, head of the gynecological cancer research group at IDIBELL, is the new president of the International Society of Gynecological Pathologists (ISGYP) since this weekend.

Dr. Xavier Matias-Guiu, the new president of the International Society of Gynecological Pathologists Read More »

Early detection of deteriorating by nursing staff improves COVID-19 patient recovery

A study finds that systematized nursing surveillance through the VIDA system, developed by the Catalan Institute of Health and IDIBELL, can detect and prevent complications, transfers to the ICU, and intra-hospital mortality.

Early detection of deteriorating by nursing staff improves COVID-19 patient recovery Read More »

The group led by Dr. Alessandra Giorgetti receives a grant from the GESMD to study myelodysplastic syndrome

The research group led by Dr. Alessandra Giorgetti, leader of the research group “Biology of Hematopoietic Stem Cells and Leukemogenesis” of IDIBELL, and professor at the UB, has received a grant of € 15,000 from the GESMD (Spanish Group of Myelodysplastic Syndromes), a group of which Giorgetti is an active member.

The group led by Dr. Alessandra Giorgetti receives a grant from the GESMD to study myelodysplastic syndrome Read More »

The impact of COVID-19 on research, analysis by Dr Capellá one year after the outbreak of the pandemic

Since the beginning of the COVID-19 pandemic, the health and scientific communities have made a formidable effort to respond, within their capabilities, to an unprecedented, rapidly evolving global situation of enormous complexity, and with a high harmful potential.

The impact of COVID-19 on research, analysis by Dr Capellá one year after the outbreak of the pandemic Read More »

Scroll to Top